RHHBY - Stifel starts Celldex at buy sees lead drug as potential blockbuster
2024-06-18 13:18:09 ET
More on Celldex
- Celldex Therapeutics: Rising High, With Room For Further Growth
- Celldex initiated to outperform at Wolfe on barzolvolimab for skin disease
- Seeking Alpha’s Quant Rating on Celldex
- Historical earnings data for Celldex
- Financial information for Celldex